Transgene SA

TNG.PA·Paris
Compare
0.6880+0.0060 (+0.88%)today
At close: Oct 16, 5:35 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.6820
Open0.6950
Day range0.68000.6950
52-week range0.67901.5000
Off day high−1.01%
Off 52-week high−54.13%
Volume46.79K
Avg. volume (3M)104.58K
Market cap191.44M
EPS (TTM)-0.1700
Forward P/E-3.13
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding278.26M
Short interest—
Earnings dateSep 16, 2025
Analyst target—
Profit margin—

Latest news

All TNG.PA news ›
MarketScreener·Positive

Transgene jumps 20% on positive cancer vaccine data in early trial

Transgene shares surged 20% in early Paris trading on Thursday, after the French biotechnology company reported positive Phase 1 trial data on its vaccine candidate for head and neck cancer. ... Biotechnology & Medical Research Transgene…

From articles in the 4Search news index.

In the news

7mentions in 30 days
7with it in the headline
Positivesentiment

Most coverage from

  1. manilatimes.net2
  2. scanx.trade2
  3. boursorama.com1
  4. marketscreener.com1
  5. whalesbook.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.